Nancy Judaun Alison, MD | |
325 N State Of Franklin Rd, 3rd Floor, Johnson City, TN 37604 | |
(423) 439-7201 | |
(423) 439-7219 |
Full Name | Nancy Judaun Alison |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 34 Years |
Location | 325 N State Of Franklin Rd, Johnson City, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679566962 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 24597 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Franklin Woods Community Hospital | Johnson city, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medical Education Assistance Corporation | 3870491269 | 145 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre...
A diagnosis of breast cancer in 2010 hit Susan Rossman pretty hard. A year later, a pioneering study at the University of Alabama at Birmingham helped her reclaim her life from cancer's grasp.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.
› Verified 8 days ago
Entity Name | Medical Education Assistance Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235180480 PECOS PAC ID: 3870491269 Enrollment ID: O20040206000795 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre...
A diagnosis of breast cancer in 2010 hit Susan Rossman pretty hard. A year later, a pioneering study at the University of Alabama at Birmingham helped her reclaim her life from cancer's grasp.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Nancy Judaun Alison, MD Po Box 699, Mountain Home, TN 37684-0699 Ph: (423) 439-7201 | Nancy Judaun Alison, MD 325 N State Of Franklin Rd, 3rd Floor, Johnson City, TN 37604 Ph: (423) 439-7201 |
News Archive
When Spire Harpenden needed to increase its facilities in response to the ever-growing number of patients choosing the hospital for surgery, it approached KARL STORZ for its market-leading OR1 NEO® integrated operating theatre...
A diagnosis of breast cancer in 2010 hit Susan Rossman pretty hard. A year later, a pioneering study at the University of Alabama at Birmingham helped her reclaim her life from cancer's grasp.
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
Hyperion Therapeutics today announced that the first patient has been enrolled in its pivotal phase III clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate). The 4-week, multi-center, randomized, double-blind, cross-over study is designed to evaluate the non-inferiority of glycerol phenylbutyrate to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder in adults with urea cycle disorders.
› Verified 8 days ago
Dr. John Clifford Johnson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Jennifer Oakley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Michael Farzin Shahbazi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Alan N Mccartt, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Amy B Young, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 | |
Calvin L Miller, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 110 Med Tech Pkwy, Johnson City, TN 37604 Phone: 423-722-0360 Fax: 423-793-1339 | |
Dr. James W Battle Iii, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Med Tech Pkwy, Suite 1, Johnson City, TN 37604 Phone: 423-929-2111 Fax: 423-929-0497 |